FindTrial
Sign In

Prognostic effects of peripheral blood circ_0003916/circ_0000672 expression and different sinus conversion strategies during radiofrequency ablation on patients with persistent atrial fibrillation

Prognostic effects of peripheral blood circ_0003916/circ_0000672 expression and different sinus conversion strategies during radiofrequency ablation on patients with persistent atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200066444
Enrollment
Unknown
Registered
2022-12-06
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Sinus rhythm control group:no
spontaneous sinus transfer group:no
Ibutilide group:Ibutilide
Electrical cardioversion group:electrical cardioversion

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 82 Years

Inclusion criteria

Inclusion criteria: Patients with persistent atrial fibrillation and atrioventricular reentrant tachycardia due to left bypass who met the guidelines for radiofrequency ablation of arrhythmias.

Exclusion criteria

Exclusion criteria: 1. Aged = 85 years; 2. valvular AF; 3. LA diameter >= 55mm assessed by echocardiography; 4. a history of radiofrequency ablation or cardiac surgery; 5. contraindication to systemic anticoagulation; 6. left atrial appendage thrombus

Design outcomes

Primary

MeasureTime frame
circ_0000672;circ_0003916;TGF-ß1;CTGF;left atrial low voltage;dynamic electrocardiogram;left atrial diameter;—

Countries

China

Contacts

Public ContactZhong Guoqiang
zhong_guoqiang111@126.com+86 15200345917

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026